Literature DB >> 2909486

Sequence homology between tetanus and botulinum toxins detected by an antipeptide antibody.

J L Halpern1, L A Smith, K B Seamon, K A Groover, W H Habig.   

Abstract

The extent of immunological similarity between tetanus toxin and botulinum toxins A, B, C1, and E was studied by using 10 antibodies produced against synthetic peptides representing different sequences of tetanus toxin, mouse antitetanus serum, and human Tetanus Immune Globulin. Antibodies produced against the synthetic peptides recognized tetanus toxin in an enzyme-linked immunosorbent assay and on Western blots (immunoblots) but did not appear to recognize the native protein. One of the antitetanus peptide antibodies, which was produced against a peptide from the amino terminal, cross-reacted with three of the four botulinum toxins on immunoblots. This antibody, 1, reacted strongly with botulinum toxins B and C1 and weakly with E but did not recognize type A toxin. None of the other peptide antibodies cross-reacted with the botulinum toxins. Mouse antitetanus serum and human Tetanus Immune Globulin did not recognize any of the botulinum toxins on immunoblots. The amino-terminal region of the light chain of tetanus toxin and botulinum toxin types A, B, C1, and E are known to have sequence homology. Our data demonstrate that for tetanus toxin and botulinum toxin types B, C1, and E this region also has immunological homology. Type A, which has the least amount of homology with tetanus toxin in this region, does not share this immunological homology. These data also suggest that although the native structures of tetanus and botulinum toxins have relatively few common immunological determinants, the two toxins may contain short stretches of identical or very similar amino acid sequences.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2909486      PMCID: PMC313034          DOI: 10.1128/iai.57.1.18-22.1989

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

1.  Antigenic structure of Clostridium botulinum type B neurotoxin and its interaction with gangliosides, cerebroside, and free fatty acids.

Authors:  S Kozaki; J Ogasawara; Y Shimote; Y Kamata; G Sakaguchi
Journal:  Infect Immun       Date:  1987-12       Impact factor: 3.441

2.  Purification of type E botulinum neurotoxin by high-performance ion exchange chromatography.

Authors:  J J Schmidt; L S Siegel
Journal:  Anal Biochem       Date:  1986-07       Impact factor: 3.365

3.  The complete nucleotide sequence of tetanus toxin.

Authors:  N F Fairweather; V A Lyness
Journal:  Nucleic Acids Res       Date:  1986-10-10       Impact factor: 16.971

Review 4.  Clostridial neurotoxins: handling and action at the cellular and molecular level.

Authors:  E Habermann; F Dreyer
Journal:  Curr Top Microbiol Immunol       Date:  1986       Impact factor: 4.291

5.  Inhibition of exocytosis in bovine adrenal medullary cells by botulinum toxin type D.

Authors:  D E Knight; D A Tonge; P F Baker
Journal:  Nature       Date:  1985 Oct 24-30       Impact factor: 49.962

Review 6.  Comparative activities of tetanus and botulinum toxins.

Authors:  J Mellanby
Journal:  Neuroscience       Date:  1984-01       Impact factor: 3.590

7.  Tetanus toxin: convulsant action on mouse spinal cord neurons in culture.

Authors:  G K Bergey; R L MacDonald; W H Habig; M C Hardegree; P G Nelson
Journal:  J Neurosci       Date:  1983-11       Impact factor: 6.167

8.  Partial amino acid sequences of botulinum neurotoxins types B and E.

Authors:  J J Schmidt; V Sathyamoorthy; B R DasGupta
Journal:  Arch Biochem Biophys       Date:  1985-05-01       Impact factor: 4.013

9.  Cloning, nucleotide sequencing, and expression of tetanus toxin fragment C in Escherichia coli.

Authors:  N F Fairweather; V A Lyness; D J Pickard; G Allen; R O Thomson
Journal:  J Bacteriol       Date:  1986-01       Impact factor: 3.490

10.  Tetanus toxin: primary structure, expression in E. coli, and homology with botulinum toxins.

Authors:  U Eisel; W Jarausch; K Goretzki; A Henschen; J Engels; U Weller; M Hudel; E Habermann; H Niemann
Journal:  EMBO J       Date:  1986-10       Impact factor: 11.598

View more
  4 in total

Review 1.  Properties and use of botulinum toxin and other microbial neurotoxins in medicine.

Authors:  E J Schantz; E A Johnson
Journal:  Microbiol Rev       Date:  1992-03

2.  Cross-reactive and strain-specific antipeptide antibodies to Pseudomonas aeruginosa PAK and PAO pili.

Authors:  K K Lee; W Paranchych; R S Hodges
Journal:  Infect Immun       Date:  1990-09       Impact factor: 3.441

3.  Cloning and expression of functional fragment C of tetanus toxin.

Authors:  J L Halpern; W H Habig; E A Neale; S Stibitz
Journal:  Infect Immun       Date:  1990-04       Impact factor: 3.441

Review 4.  Immunogenicity of botulinum toxins.

Authors:  Markus Naumann; Lee Ming Boo; Alan H Ackerman; Conor J Gallagher
Journal:  J Neural Transm (Vienna)       Date:  2012-09-25       Impact factor: 3.575

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.